Skip to main content

Evaluation of the effectiveness of antibody immobilisation techniques

Image: National Institute of Standards and Technology, public domain, via Wikimedia Commons (licence). Cropped and resized. Image credits
  • European Social Fund (ESF)
  • 3 Nov 2020 to 30 Apr 2021
  • Lithuania

Project page and source record Share by email Share on LinkedIn

Participants, websites and capabilities are shown to signed-in members.Sign in or request access

Operation co-funded by EU cohesion policy (European Social Fund (ESF)) under the programme EU Structural Funds Investments - LT - ERDF/ESF/CF/YEI (2014LT16MAOP001), managing authority: Finansų ministerija. The source names no beneficiary for this operation. Location: Vilnius County (NUTS LT011); Lithuania. Budget: total eligible expenditure EUR 2,999.54; EU co-financing EUR 2,999.54 (co-financing rate 100%), as stated by the source. Runs 2020-11-03 to 2021-04-30. Source: Kohesio, EU cohesion policy projects managed by national and regional authorities (not CORDIS); selected because its summary names quantum technology. Summary from Kohesio (English machine translation by the source): The number of new cancer cases in the world is projected to rise to 22 million per year over the next 2 decades, while the number of cancer deaths will increase from around 8.2 million per year. The sensitivity of current cancer detection methods is not high enough to detect abnormalities at cellular level, so our ability to perform early cancer diagnosis is severely limited and it is important to develop new methods with a higher sensitivity. One possible option is optical analytical systems, where quantum dots and magnetic particles are used to enhance the analytical signal. The project will examine methods of immobilisation and conjugation of specific antibodies to improve the performance of optical analytical systems.

Original source.

Source: Kohesio (EU cohesion policy projects), European Commission, Directorate-General for Regional and Urban Policy (DG REGIO). Retrieved 2026-10-21. Licence: CC0 1.0 (Cohesion Open Data Platform, dataset 2014-2020 Kohesio projects). Selected metadata, adapted presentation; the publisher's record is authoritative. No endorsement by the source is implied. Licence: public domain dedication (CC0 1.0).

AI-assisted summary: The operation evaluates antibody immobilisation techniques and is co-funded by the EU under the ESF, with a total budget of EUR 2,999.54. It runs from November 3, 2020, to April 30, 2021, in Vilnius County, Lithuania. Suggested technology pillar: sensing. Generated by AI from the public source text; it may contain errors and the original source is authoritative.

Source: kohesio.ec.europa.eu · checked 21 Oct 2026 · AI-assisted summary